Experiments with pharmacologic sympatholysis in the gravid.
D000328:Adult; D000818:Animals; D004285:Dogs; D005260:Female; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D008750:Methyldopa / Q000627:therapeutic use*; D007752:Obstetric Labor, Premature / Q000517:prevention & control; D010121:Oxytocin / Q000494:pharmacology / Q000627:therapeutic use; D010643:Phenoxybenzamine / Q000494:pharmacology* / Q000627:therapeutic use*; D010646:Phentolamine / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011433:Propranolol / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D012110:Reserpine / Q000494:pharmacology* / Q000627:therapeutic use; D014043:Tolazoline / Q000494:pharmacology* / Q000627:therapeutic use*; D014599:Uterus / Q000187:drug effects*; D014665:Vasodilator Agents / Q000494:pharmacology* / Q000627:therapeutic use*
D014665:Vasodilator Agents; D006852:Hydrochlorothiazide; D010643:Phenoxybenzamine; D010121:Oxytocin; D008750:Methyldopa; D012110:Reserpine; D011433:Propranolol; D014043:Tolazoline; D010646:Phentolamine; D006145:Guanethidine